L.p. Fund Impact Oncology Ubs

Affiliations

  • Large Shareholder at Tcr2 Therapeutics Inc. (TCRR), 2023-06-05
  • Large Shareholder at Iteos Therapeutics Inc. (ITOS), 2022-01-06
  • Large Shareholder at Cullinan Oncology Inc. (CGEM), 2021-09-20
  • Large Shareholder at Harpoon Therapeutics Inc. (HARP), 2021-06-02
  • Large Shareholder at Werewolf Therapeutics Inc. (HOWL), 2021-05-06
  • Large Shareholder at Oncorus Inc. (ONCR), 2020-10-08
  • Large Shareholder at Spring Bank Pharmaceuticals Inc. (SBPH), 2018-02-06
  • Large Shareholder at Sunesis Pharmaceuticals Inc (SNSS), 2017-11-07
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CGEM $21.00 300,000 Large Shareholder 7,913,887 2021-01-12 Filing
ONCR $15.00 151,224 Large Shareholder 2,377,025 2020-10-06 Filing
TCRR $15.00 666,667 Large Shareholder 3,370,982 2019-02-19 Filing
HARP $14.00 250,000 Large Shareholder 3,898,422 2019-02-12 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CGEM $29.06 3,124 Large Shareholder 7,648,268 2021-09-16 Filing
CGEM $29.16 6,425 Large Shareholder 7,651,392 2021-09-15 Filing
CGEM $29.17 7,106 Large Shareholder 7,657,817 2021-09-14 Filing
CGEM $29.10 3,595 Large Shareholder 7,664,923 2021-09-13 Filing
CGEM $29.04 5,931 Large Shareholder 7,668,518 2021-09-10 Filing